$REVB
REVELATION BIOSCIENCES, INC.

2020 Form 10-K Financial Statement

#000121390022020179 Filed on April 15, 2022

View on sec.gov

Income Statement

Concept 2020
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $145.5K
YoY Change 3896.98%
% of Gross Profit
Research & Development $1.707M
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $145.5K
YoY Change 3896.98%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$1.494M
YoY Change
Pretax Income -$1.631M
YoY Change 44693.96%
Income Tax
% Of Pretax Income
Net Earnings -$1.631M
YoY Change 44693.96%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$179.2K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $537.0K
YoY Change
Cash & Equivalents $11.73K
Short-Term Investments $525.3K
Other Short-Term Assets $114.3K
YoY Change 404.06%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $651.3K
YoY Change 2772.92%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $73.51M
YoY Change
Total Long-Term Assets $73.51M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $651.3K
Total Long-Term Assets $73.51M
Total Assets $74.16M
YoY Change 327038.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $865.9K
YoY Change
Accrued Expenses $33.77K
YoY Change 107.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.434M
YoY Change 12950.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $2.911M
YoY Change
Total Long-Term Liabilities $2.911M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.434M
Total Long-Term Liabilities $2.911M
Total Liabilities $6.345M
YoY Change 24015.96%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $67.82M
YoY Change
Total Liabilities & Shareholders Equity $74.16M
YoY Change 327038.11%

Cashflow Statement

Concept 2020
OPERATING ACTIVITIES
Net Income -$1.631M
YoY Change 44693.96%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$216.7K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$74.04M
YoY Change
Cash From Investing Activities -$74.04M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.100M
YoY Change -61100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 74.26M
YoY Change
NET CHANGE
Cash From Operating Activities -216.7K
Cash From Investing Activities -74.04M
Cash From Financing Activities 74.26M
Net Change In Cash 11.73K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$216.7K
Capital Expenditures $0.00
Free Cash Flow -$216.7K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001810560
CY2021 dei City Area Code
CityAreaCode
650
CY2021 dei Local Phone Number
LocalPhoneNumber
800-3717
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2020 us-gaap Interest Expense
InterestExpense
USD
CY2020 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
USD
CY2021 us-gaap Held To Maturity Securities Transferred To Trading Securities Unrealized Gain Loss
HeldToMaturitySecuritiesTransferredToTradingSecuritiesUnrealizedGainLoss
USD
CY2020 revb Cancellation Of Founders Shares
CancellationOfFoundersShares
USD
CY2020 revb Cash Paid From Trust Account For Redemption Of Common Stock
CashPaidFromTrustAccountForRedemptionOfCommonStock
USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
USD
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
USD
CY2021 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
USD
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
USD
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
USD
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
USD
CY2021 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
USD
CY2020 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
USD
CY2021 revb Investment In Marketable Securities
InvestmentInMarketableSecurities
USD
CY2021 revb Increase Decrease In Deferred Offering Costs
IncreaseDecreaseInDeferredOfferingCosts
USD
CY2021 revb Common Stock Issued In Partial Relief Of Related Party Note Payable
CommonStockIssuedInPartialReliefOfRelatedPartyNotePayable
USD
CY2021 revb Cancellation Of Founders In Shares
CancellationOfFoundersInShares
USD
CY2021 us-gaap Stock Issued1
StockIssued1
USD
CY2021 revb Advance Converted To Related Party Note Payable
AdvanceConvertedToRelatedPartyNotePayable
USD
CY2021 revb Private Warrants Recorded As Liability
PrivateWarrantsRecordedAsLiability
USD
CY2019Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD

Files In Submission

Name View Source Status
0001213900-22-020179-index-headers.html Edgar Link pending
0001213900-22-020179-index.html Edgar Link pending
0001213900-22-020179.txt Edgar Link pending
0001213900-22-020179-xbrl.zip Edgar Link pending
f10k2021ex31-1_revelation.htm Edgar Link pending
f10k2021ex31-2_revelation.htm Edgar Link pending
f10k2021ex32-1_revelation.htm Edgar Link pending
f10k2021ex32-2_revelation.htm Edgar Link pending
f10k2021ex4-9_revelation.htm Edgar Link pending
f10k2021_revelationbio.htm Edgar Link pending
f10k2021_revelationbio_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
image_003.jpg Edgar Link pending
image_004.jpg Edgar Link pending
image_005.jpg Edgar Link pending
image_006.jpg Edgar Link pending
image_007.jpg Edgar Link pending
image_008.jpg Edgar Link pending
image_009.jpg Edgar Link pending
image_010.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
revb-20211231.xsd Edgar Link pending
revb-20211231_cal.xml Edgar Link unprocessable
revb-20211231_def.xml Edgar Link unprocessable
revb-20211231_lab.xml Edgar Link unprocessable
revb-20211231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending